🇺🇸 FDA
Pipeline program

Nifedipine (Adalat, BAYA1040)

13176

Phase 3 small_molecule completed

Quick answer

Nifedipine (Adalat, BAYA1040) for Hypertension is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bayer HealthCare AG
Indication
Hypertension
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials